|
|
|
 |
| Location: Home -
Products - API Intermediates - API Intermediates
|
Barasertib(AZD1152-HQPA)
| Catalogue No. : |
C13349 |
| Product Name: |
Barasertib(AZD1152-HQPA) |
| Synonym: |
Barasertib;AZD 1152HQPA;INH 34;AZD1152-Hydroxyquinazoline Pyrazol Anilide |
| Chemical Name: |
2-(5-((7-3-(Ethyl(2-hydroxyethyl)amino)propoxy)quinazolin-4-yl)amino)-1H-pyrazol-3-yl)-N-(3-fluorophenyl)acetamide;5-[[7-[3-[Ethyl(2-hydroxyethyl)amino]propoxy]-4-quinazolinyl]amino]-N-(3-fluorophenyl)-1H-pyrazole-3-acetamide |
| CAS No. : |
722544-51-6 |
| Structure : |
|
| Molecular Formula: |
C26H30FN7O3 |
| Molecular Weight: |
507.56 |
| Appearance: |
Crystalline solid |
| Purity: |
>99% |
| Usage: |
AZD1152-HQPA is a a highly selective inhibitor of aurora-B kinase. AZD1152-HQPA has been shown to inhibit osteosarcoma cell line U2-OS cells proliferation. AZD1152-HQPA was also shown to be an effective apoptosis-inducing agent in acute myeloid leukemia cell lines and primary acute myeloid leukemia cultures. |
|
| Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. As it is impossible for us to be informed about the patent situation in all countries, the liability for patent infringement is exclusively to be understood as buyer's risk. |
|
|
